Keywords: gsk/china, deal, hiv/aids, drugs, glaxosmithkline, agreed, sell

GSK/China deal for HIV/AIDS drugs

Article | 26 July 2004

Print This

GlaxoSmithKline has agreed to sell its antiretroviral Epivir(lamivudine) in China at preferential prices until 2006 and may also start making ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in